What’s most intriguing about change is its complexity. Change is a game of polar opposites that both scares and excites. The change that is the most necessary is not always the most comfortable. The change that makes us the most uncomfortable often produces the most growth.

It was several years ago that I was first introduced to the world of clinical research. Coming from automotive and tech industries, I was immediately drawn to solving some of the key bottlenecks in the drug development process. Researchers and patients alike are underserved by antiquated systems, while leadership are incentivized to keep to the established way things work – no matter what it meant for the patients, the researchers, or skyrocketing drug prices. Improbable and uncomfortable changes have been overdue.

“Sometimes it is the people no one imagines anything of who do the things that no one can imagine.” – Alan Turing/Benedict Cumberbatch, The Imitation Game (2015)

Yes, tech entrepreneurs like the LeapCure team have the chutzpah to challenge the massive constraints weighing on healthcare. Yes, researchers dedicate their lives, push through incredible hurdles, are often poorly funded, and strive to bring new drugs to market against all odds. However, it’s patients that will create the change to our drug development processes. Many of these patients fight terrible conditions, they’re left behind by society, their voices are often deprioritized. Still, they risk what they can to give us all a better chance at healthy lives.

This is where LeapCure enters. Improving clinical research is our business and our passion. We aim to use our technology to empower patients, accelerate clinical research, and eventually shave multiple years off of drug development.

LeapCure’s study screening technology is only the beginning. Check out LeapCure.com and join us on a journey to change the pace of research.

Zachary Gobst

Co-Founder & CEO

LeapCure